Phospho-TPH2 (Ser19) Antibody

What is TPH2 and why is the phosphorylation at Ser19 significant?

TPH2 (Tryptophan hydroxylase 2) is the neuronal form of tryptophan hydroxylase that catalyzes the rate-limiting step in the biosynthesis of serotonin. Unlike TPH1 (found in peripheral tissues), TPH2 contains an additional 41 amino acids at the N-terminus that includes the Ser19 phosphorylation site .

The phosphorylation at Ser19 is significant because:

• It counteracts reduced stability in the N-terminal regulatory domain of TPH2

• It increases enzyme expression and activity by approximately 30%

• It's catalyzed by both PKA (protein kinase A) and CaMKII (calmodulin-dependent protein kinase II)

• It enables binding to 14-3-3 proteins, which further stabilize and activate the enzyme

• It serves as a key post-translational mechanism for regulating serotonin synthesis

Research shows that forskolin-mediated activation of PKA results in significant increases in expression of TPH2, with subsequent increases in 5-HTP and serotonin production .

How does phosphorylated TPH2 at Ser19 differ functionally from unphosphorylated TPH2?

Phosphorylated TPH2 at Ser19 exhibits several key functional differences:

Experimental evidence demonstrates that mutation of Ser19 to alanine (S19A) prevents phosphorylation and reduces forskolin-induced increases in expression, while mutation to aspartate (S19D, mimicking phosphorylation) results in 2-3 times higher baseline expression levels without further response to forskolin treatment .

What research applications are appropriate for Phospho-TPH2 (Ser19) antibodies?

Phospho-TPH2 (Ser19) antibodies are utilized in multiple research applications:

• Western Blotting: Most commonly used application with recommended dilutions of 1:500-1:2000 for detecting phosphorylated TPH2 in cell/tissue lysates

• ELISA: For quantitative measurement, typically using dilutions around 1:40000

• Immunohistochemistry/Immunofluorescence: For visualizing phosphorylated TPH2 in tissue sections or cells

• Phosphorylation dynamics studies: For examining how cellular signaling affects TPH2 phosphorylation status

• Drug screening: For identifying compounds that modulate TPH2 phosphorylation

• Neuropsychiatric disorder research: For studying potential alterations in TPH2 regulation in conditions like depression and bipolar disorder

When designing experiments, it's crucial to include proper controls such as S19A mutants (phosphorylation-deficient) and phosphatase-treated samples to validate antibody specificity .

What are the optimal sample preparation methods when using Phospho-TPH2 (Ser19) antibodies?

Proper sample preparation is critical for preserving and detecting TPH2 phosphorylation at Ser19:

• Tissue/Cell Harvesting:

  • Rapidly process samples to prevent dephosphorylation

  • Flash-freeze brain tissue in liquid nitrogen immediately after harvesting

  • For cultured cells, quickly rinse with ice-cold PBS before lysis

• Lysis Buffer Components:

  • Phosphatase inhibitors: Include sodium fluoride (50mM), sodium orthovanadate (1mM), and β-glycerophosphate (10mM)

  • Protease inhibitors: Add complete protease inhibitor cocktail

  • Buffer base: RIPA or NP-40 based buffers (pH 7.4) work well for TPH2 extraction

• Processing Conditions:

  • Maintain samples at 4°C throughout processing

  • Homogenize tissues using appropriate mechanical disruption

  • Clarify lysates by centrifugation (14,000×g, 15 min, 4°C)

• Protein Quantification and Storage:

  • Determine protein concentration using Bradford or BCA assay

  • Aliquot samples to avoid freeze-thaw cycles

  • Store at -80°C for long-term preservation of phosphorylation

• Experimental Enhancement:

  • For positive controls, treat cells with forskolin (10μM, 30 min) to increase Ser19 phosphorylation

  • Include S19A mutant-expressing cells as negative controls

Consistent sample preparation is essential for comparative analyses of phosphorylation states across different experimental conditions.

How can researchers experimentally manipulate TPH2 phosphorylation at Ser19?

TPH2 phosphorylation at Ser19 can be manipulated through several experimental approaches:

• Increasing Phosphorylation:

  • PKA pathway activation: Treat cells with forskolin (10μM) to increase cAMP and activate PKA

  • Direct PKA activation: Apply dibutyryl-cAMP (cell-permeable cAMP analog)

  • CaMKII activation: Use calcium ionophores or glutamate receptor agonists to increase calcium levels

  • Phosphatase inhibition: Apply okadaic acid or calyculin A to inhibit protein phosphatases

• Decreasing Phosphorylation:

  • PKA inhibition: Treat with H-89 (PKA inhibitor, 10μM)

  • CaMKII inhibition: Apply KN-93 (CaMKII inhibitor)

  • Phosphatase treatment: Incubate samples with lambda phosphatase or alkaline phosphatase

• Genetic Manipulation:

  • Site-directed mutagenesis: Generate S19A mutant (prevents phosphorylation) or S19D mutant (mimics phosphorylation)

  • Expression systems: Transfect cells with wild-type or mutant TPH2 constructs

  • CRISPR-Cas9: Create knock-in mutations at the Ser19 site in cellular models

• Physiological Manipulations:

  • Neurotransmitter modulation: Apply serotonergic drugs to alter feedback regulation

  • Stress models: Use animal stress paradigms that naturally modulate TPH2 phosphorylation

Validation of phosphorylation changes should be performed using Phospho-TPH2 (Ser19) antibodies in Western blot or ELISA experiments, with total TPH2 measurement as normalization control.

What are the critical factors for validating Phospho-TPH2 (Ser19) antibody specificity?

Rigorous validation of Phospho-TPH2 (Ser19) antibody specificity involves multiple complementary approaches:

• Molecular Controls:

  • Peptide competition: Pre-incubate antibody with phosphopeptide immunogen (G-F-S(p)-L-D peptide) to block specific binding

  • Mutant controls: Test against S19A mutant TPH2 (should show no signal)

  • Phosphomimetic controls: Use S19D mutant as a reference for phosphorylation-dependent functions

• Enzymatic Treatments:

  • Phosphatase treatment: Treat duplicate samples with lambda phosphatase to remove phosphate groups

  • Kinase treatments: Incubate recombinant TPH2 with purified PKA and ATP to increase phosphorylation

• Stimulation Experiments:

  • Forskolin treatment: Treat cells with forskolin to increase PKA-mediated phosphorylation

  • Compare stimulated vs. basal conditions: Signal should increase with stimulation

• Cross-reactivity Testing:

  • TPH1 testing: Confirm no cross-reactivity with TPH1 (lacks Ser19)

  • Other phosphoproteins: Test against proteins with similar phosphomotifs (e.g., Phospho-TH-Ser19)

• Technical Validation:

  • Multiple antibody comparison: Compare results from different Phospho-TPH2 (Ser19) antibodies

  • Mass spectrometry confirmation: Verify phosphorylation using MS-based methods

A robust validation protocol example: Express both wild-type TPH2 and S19A mutant in cells, treat half of each with forskolin, then immunoblot with both phospho-specific and total TPH2 antibodies. The phospho-antibody should show increased signal with forskolin treatment only in wild-type samples.

How can researchers design experiments to study the dynamics of TPH2 phosphorylation at Ser19?

Designing sophisticated experiments to study TPH2 Ser19 phosphorylation dynamics requires multi-dimensional approaches:

• Temporal Analysis:

  • Time-course experiments: Stimulate cells with forskolin and collect samples at multiple time points (0, 5, 15, 30, 60 minutes)

  • Pulse-chase analysis: Use 32P-orthophosphate labeling followed by immunoprecipitation to track phosphorylation/dephosphorylation rates

  • Kinetics measurement: Calculate the rate constants of phosphorylation and dephosphorylation under various conditions

• Pharmacological Interrogation:

  • Kinase/phosphatase inhibitor panels: Apply specific inhibitors to identify the regulatory enzymes controlling TPH2 phosphorylation

  • Dose-response relationships: Determine EC50 values for activators like forskolin

  • Combination treatments: Test synergistic effects of multiple pathway activators

• Cellular Compartmentalization:

  • Subcellular fractionation: Analyze phosphorylation status in different cellular compartments

  • Immunofluorescence microscopy: Track localization changes dependent on phosphorylation

  • In situ proximity ligation assay: Visualize phosphorylated TPH2 interactions with partner proteins

• Quantitative Readouts:

  • Quantitative Western blotting: Use fluorescent secondary antibodies for linear range detection

  • ELISA development: Create sandwich ELISA with capture antibody against TPH2 and detection with Phospho-TPH2 (Ser19) antibody

  • Mass spectrometry: Employ parallel reaction monitoring for quantitative analysis of Ser19 phosphopeptides

• Functional Correlation:

  • Activity assays: Measure TPH2 enzymatic activity in parallel with phosphorylation status

  • Serotonin production: Quantify 5-HTP and serotonin levels using HPLC

  • Protein stability assessment: Track protein half-life changes dependent on phosphorylation state

Example experimental workflow:

• Express wild-type TPH2 in an appropriate cellular model

• Pretreat with selective inhibitors or vehicle controls

• Stimulate with forskolin for various times

• Process samples for both phosphorylation analysis and functional readouts

• Correlate phosphorylation dynamics with functional outcomes

What does research reveal about TPH2 Ser19 phosphorylation in neuropsychiatric disorders?

Research on TPH2 Ser19 phosphorylation has revealed several implications for neuropsychiatric disorders:

• Mood Disorders:

  • Altered TPH2 phosphorylation may contribute to serotonin deficiency in depression

  • The S41Y polymorphism (C2755A) near Ser19 is associated with bipolar disorder and peripartum depression

  • This polymorphism reduces PKA-mediated phosphorylation by approximately 50%

• Neurophysiological Abnormalities:

  • Reduced TPH2 levels and potentially altered phosphorylation have been reported in Sudden Infant Death Syndrome (SIDS)

  • TPH2 phosphorylation abnormalities may disrupt brainstem serotonergic control of autonomic functions

• Therapeutic Implications:

  • Some antidepressants may work partly by enhancing TPH2 phosphorylation and activity

  • Targeting mechanisms to enhance TPH2 phosphorylation might represent a novel approach for treating serotonin-related disorders

• Genetic-Functional Interactions:

  • The S41Y variant increases intrinsic enzyme activity in vitro but paradoxically decreases serotonin production in cells

  • This suggests complex regulatory mechanisms beyond simple enzyme activity

• Stress Response Mechanisms:

  • Stress-induced changes in TPH2 phosphorylation may link environmental stressors to mood disorders

  • PKA signaling pathway dysregulation affects TPH2 phosphorylation and serotonin synthesis

Research data indicates that properly regulated TPH2 phosphorylation is crucial for maintaining normal serotonergic function, and disruptions in this process may contribute to the pathophysiology of several psychiatric disorders.

How does the interaction between phosphorylated TPH2 and 14-3-3 proteins affect enzyme function?

The interaction between phosphorylated TPH2 and 14-3-3 proteins represents a sophisticated regulatory mechanism:

• Binding Mechanism:

  • Phosphorylation at Ser19 creates a recognition motif for 14-3-3 proteins

  • Purified PKA-phosphorylated TPH2 binds to 14-3-3 proteins γ, ϵ, and BMH1 with high affinity

  • The binding is phosphorylation-dependent and does not occur with unphosphorylated TPH2

• Functional Consequences:

  • Enhanced stability: 14-3-3 binding protects phosphorylated TPH2 from degradation

  • Increased activity: Binding causes a further increase in enzyme activity beyond phosphorylation alone

  • Conformational changes: 14-3-3 proteins may induce structural changes that optimize TPH2 catalytic function

• Regulatory Significance:

  • 14-3-3 proteins act as "molecular anvils" that consolidate and strengthen the effects of phosphorylation

  • This creates a two-step regulatory mechanism: first phosphorylation, then 14-3-3 binding

  • The interaction extends the duration of phosphorylation-induced activation

• Neurobiological Implications:

  • 14-3-3 proteins may be important for the regulation of serotonin function in the nervous system

  • Dysregulation of this interaction could contribute to serotonergic abnormalities in psychiatric disorders

• Methodological Approaches to Study the Interaction:

  • Co-immunoprecipitation of TPH2 with 14-3-3 proteins

  • Pull-down assays with GST-tagged 14-3-3 proteins

  • Surface plasmon resonance to measure binding kinetics

  • Functional enzyme assays in the presence and absence of 14-3-3 proteins

This sophisticated regulatory mechanism highlights the importance of studying not just phosphorylation events themselves but also their downstream effects through protein-protein interactions.

How do TPH2 mutations near the Ser19 site impact phosphorylation and enzyme function?

Mutations in the vicinity of the Ser19 phosphorylation site can profoundly affect TPH2 regulation and function:

• S41Y Mutation (C2755A):

  • Located in the regulatory domain near Ser19

  • Reduces PKA-mediated phosphorylation at Ser19 by approximately 50%

  • Increases intrinsic enzyme activity in vitro but paradoxically decreases serotonin production in cells

  • Associated with bipolar disorder and peripartum depression in clinical studies

• Molecular Mechanisms of Mutation Effects:

  • Conformational changes: Mutations may alter protein structure, making Ser19 less accessible to kinases

  • Kinase recognition: Changes in the surrounding sequence can modify the recognition motif for PKA or CaMKII

  • Phosphatase interactions: Mutations may enhance recruitment of phosphatases that dephosphorylate Ser19

  • Regulatory domain function: The N-terminal region (residues 10-20) is critical for protein stability

• Experimental Observations:

  • The S41Y mutation results in higher TPH2 protein levels but reduced serotonin synthesis

  • This suggests the mutation disrupts normal post-translational regulation despite increased expression

  • The S41Y variant exhibits decreased enzyme stability in vitro (half-life reduced from 32 to 4 minutes at 37°C)

• Structural Considerations:

  • The regulatory domain of TPH2 (including Ser19) has not been fully characterized structurally

  • This domain is likely highly mobile and may interact with the catalytic domain to control substrate access

  • Mutations may disrupt these inter-domain interactions

• Therapeutic Relevance:

  • Understanding how mutations affect phosphorylation helps in developing personalized treatment approaches

  • Patients with mutations affecting Ser19 phosphorylation might respond differently to serotonergic medications

These findings highlight the complex relationship between TPH2 structure, phosphorylation, and function, with implications for understanding both normal serotonergic regulation and pathological states.

What methodologies exist for accurately quantifying TPH2 phosphorylation stoichiometry?

Accurate quantification of TPH2 phosphorylation stoichiometry requires sophisticated methodological approaches:

• Radiometric Methods:

  • 32P-ATP labeling: Incubate purified TPH2 with PKA and 32P-ATP

  • Phosphate incorporation measurement: Determine mol phosphate/mol protein ratio

  • Advantages: Direct measurement of phosphate incorporation

  • Limitations: Requires radioisotope handling

• Mass Spectrometry-Based Approaches:

  • Selected/Multiple Reaction Monitoring (SRM/MRM): Target specific phosphopeptides containing Ser19

  • Parallel Reaction Monitoring (PRM): For improved selectivity

  • Absolute quantification: Use synthetic phosphopeptide internal standards

  • Advantages: High specificity and sensitivity

  • Limitations: Requires specialized equipment and expertise

• Antibody-Based Methods:

  • Quantitative Western blotting: Use fluorescent secondary antibodies for linear detection

  • ELISA: Develop sandwich assays with capture antibody against total TPH2 and detection with phospho-specific antibody

  • Calibration: Use recombinant phosphorylated TPH2 standards with known stoichiometry

  • Advantages: Accessible technology

  • Limitations: Dependent on antibody specificity

• Electrophoretic Approaches:

  • Phos-tag™ SDS-PAGE: Separates phosphorylated from non-phosphorylated protein forms

  • Isoelectric focusing: Resolves different phosphorylation states based on charge

  • Two-dimensional electrophoresis: Combines isoelectric focusing with SDS-PAGE

  • Advantages: Visual separation of phospho-states

  • Limitations: May not resolve complex phosphorylation patterns

• Calibration Standards Development:

  • Create standards with defined phosphorylation ratios by mixing phosphorylated and non-phosphorylated recombinant TPH2

  • Use these standards to generate calibration curves for unknown samples

Research has shown that in cells, basal phosphorylation of TPH2 at Ser19 can reach up to 50% stoichiometry, with further increases upon forskolin treatment , making accurate quantification methods essential for understanding this regulatory mechanism.

What are the key differences between antibodies detecting phospho-TPH2 (Ser19) versus phospho-TH (Ser19)?

Distinguishing between antibodies against phospho-TPH2 (Ser19) and phospho-TH (Ser19) is critical in neuroscience research:

• Target Protein Differences:

  • TPH2: Tryptophan hydroxylase 2, the rate-limiting enzyme in serotonin synthesis

  • TH: Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine synthesis

  • Both are aromatic amino acid hydroxylases but function in different neurotransmitter pathways

• Phosphorylation Site Context:

  • TPH2 Ser19: Located within sequence G-F-S(p)-L-D

  • TH Ser19: Found within a different sequence context

  • Despite identical residue numbers, these are distinct phosphorylation sites in different proteins

• Antibody Generation:

  • Phospho-TPH2 (Ser19): Typically generated using synthetic phosphopeptides derived from human TPH2 around Ser19

  • Phospho-TH (Ser19): Generated using phosphopeptides from the TH sequence around Ser19

  • Both are commonly produced in rabbits as polyclonal antibodies

• Functional Significance:

  • TPH2 Ser19 phosphorylation: Regulates serotonin synthesis through increased stability and activity

  • TH Ser19 phosphorylation: Regulates catecholamine synthesis through different mechanisms

  • Both affect neurotransmitter production but in different neuronal populations

• Cross-reactivity Considerations:

  • Due to potential sequence similarities between phosphorylation motifs, cross-reactivity testing is essential

  • Validation using phosphopeptide competition and recombinant proteins is recommended

  • When studying brain tissues containing both enzymes, specificity must be carefully verified

When selecting antibodies for research, scientists should examine the immunogen sequence and validation data to ensure specificity for their target of interest, especially when studying mixed neuronal populations.

What are the analytical challenges in detecting endogenous phospho-TPH2 (Ser19) in brain tissue samples?

Detection of endogenous phospho-TPH2 (Ser19) in brain tissue presents several significant analytical challenges:

• Sample Preservation Challenges:

  • Rapid post-mortem changes: Phosphorylation states deteriorate quickly after death

  • Phosphatase activation: Brain tissue contains high levels of phosphatases that are activated during sample processing

  • Solution: Rapid freezing in liquid nitrogen immediately after tissue collection and inclusion of phosphatase inhibitor cocktails in all buffers

• Signal Abundance Issues:

  • Low expression levels: TPH2 is expressed primarily in raphe nuclei neurons, which constitute a small percentage of brain cells

  • Partial phosphorylation: Only a fraction of total TPH2 may be phosphorylated at Ser19

  • Solution: Enrichment strategies such as immunoprecipitation prior to detection

• Specificity Concerns:

  • Cross-reactivity: Antibodies may detect other phosphoproteins with similar epitopes

  • Multiple phosphorylation sites: TPH2 is phosphorylated at both Ser19 and Ser104

  • Solution: Validation with S19A mutant controls and phosphopeptide competition assays

• Anatomical Precision Requirements:

  • Regional specificity: TPH2 expression is restricted to specific brainstem nuclei

  • Cellular heterogeneity: Brain tissue contains multiple cell types

  • Solution: Laser capture microdissection of serotonergic neurons or fluorescence-activated cell sorting

• Quantification Challenges:

  • Reference standards: Lack of defined standards for phosphorylation stoichiometry

  • Normalization issues: Total TPH2 levels may vary across samples

  • Solution: Development of absolute quantification methods using synthetic phosphopeptides

• Methodological Recommendations:

  • Use modified RIPA buffers with multiple phosphatase inhibitors

  • Consider phospho-enrichment strategies (TiO2, IMAC) prior to detection

  • Implement tissue preservation protocols optimized for phosphoproteins

  • Develop targeted mass spectrometry methods for confirmation